Home Podcasts AUTM on the Air
AUTM on the Air

AUTM on the Air

AUTM 305 episodes Latest Jun 3, 2026

AUTM on the AIR is a weekly podcast that explores the impact of research commercialization and the people behind it. It features interviews with patent and licensing professionals, innovators, entrepreneurs, and tech transfer leaders, discussing the issues and trends that matter most in the field.

Episodes

How Novartis Approaches External Research Collaboration with Dr. Yogesh Sharma Jun 10, 2026 1599 University-industry partnerships often sound straightforward from the outside. A promising discovery is made, a company sees potential, and a collaboration begins. But anyone who has worked inside these agreements knows the reality is far more complex. Research goals, publication timelines, IP rights, background technology, data sources, and internal review processes all have to be understood befo
Bridging the Early-Stage Funding Gap in Innovation with Teri Willey Jun 3, 2026 1762 There’s a stretch of time in innovation where things feel the most uncertain, when the science is promising but the path forward isn’t clear and the capital hasn’t quite caught up. It’s a space that can quietly stall even the most compelling ideas. In this episode, the conversation zeroes in on that early stage gap and what it really takes to move something forward when the usual funding sources a
Detecting Alzheimer’s Earlier with a Simple Blood Test with Yuanbing Jiang May 27, 2026 1373 Early detection is everything when it comes to Alzheimer’s, but for years, the tools available have made that nearly impossible at scale. Today’s conversation takes a closer look at a breakthrough that could change that equation in a very real way. My guest is Dr. Yuanbing Jiang, also known as Jason, a research assistant professor in the Division of Life Science at the Hong Kong University of Scie
Turning Research into Real World Impact from the Inside Out with Ravini Moodley May 20, 2026 1452 Most people focus on the breakthrough, but there is a massive gap between a scientific discovery and a product that actually reaches the public. Today, we’re stepping into the "engine room" of one of Africa’s premier research institutions to see how that gap is bridged. My guest is Ravini Moodley, Director of the Technology Transfer Office at Stellenbosch University’s Innovus. She has a ba
Timing, Trust, and Technical Credibility Building, the Long Game with Ram Krishnan May 13, 2026 1814 One of the biggest shifts in technology transfer over the past decade isn’t just the pace of innovation. It’s the realization that value isn’t created at a single moment. It builds over time, shaped by how well research, intellectual property, and real-world application stay aligned. The challenge isn’t only generating strong ideas. It’s understanding how those ideas evolve, how they’re protected,
The Missing Link Between Research and Real-World Impact with Ben Reinhardt May 6, 2026 2148 There’s a moment every tech transfer professional recognizes, when a discovery feels like it could matter, but you can’t quite see how it gets from the lab into the real world. That gap is where a lot of promising ideas stall out. In this episode, the conversation takes a closer look at that in-between space and asks a simple but uncomfortable question: what if the problem isn’t just funding or ti
Thriving in Small Tech Transfer Offices with Caitlin Long and Sanaz Shahi Apr 29, 2026 1317 Collaboration is one of the defining strengths of the technology transfer community, and it often becomes even more important when resources are limited. This conversation takes a closer look at what it really means to operate in a small or under-resourced office, where the work can feel both expansive and unpredictable. From managing intellectual property to handling budgets, compliance, and stak
Cleaning Up Forever: How AI and Membrane Science Are Taking PFAS Out of Our Water with Dr. Yongsheng Chen Apr 22, 2026 1782 Clean water plays a fundamental role in health, safety, and quality of life. This Earth Day conversation takes a closer look at PFAS, often called “forever chemicals,” and the growing challenge they pose to drinking water systems across the United States and beyond. My guest is Dr. Yongsheng Chen, a professor in the School of Civil and Environmental Engineering at Georgia Institute of Technology a
Startup Success Starts with the Problem, Not the Tech with Marc Filerman Apr 15, 2026 3187 Turning research into something that actually works in the real world sounds straightforward, but it rarely is. There’s a gap between discovery and impact that trips up even the most promising ideas, and it often has less to do with the science and more to do with how the problem is framed, understood, and communicated. My guest today is Marc Filerman, Chief Business Officer at Start2 Group, a glo
Deciding When Research Should Become a Startup with Omar Zahr Apr 8, 2026 1559 One of the toughest calls in technology transfer isn’t deciding whether a discovery is interesting or even promising. It’s deciding whether that discovery should become a company at all. There’s a big difference between a strong piece of research and something that can support a venture-backed startup, and most of the real work happens in that space in between.My guest today is Omar Zahr, Chief Te
Building Strong Industry Academic Partnerships with Mark Fairey Apr 1, 2026 1191 Some of the most meaningful industry–academic partnerships don’t begin with a breakthrough headline or a flashy piece of technology. More often, they take shape around a real research need, a practical solution, and a willingness to keep showing up and working through the details over time. That’s the kind of collaboration we’re exploring here, including how ideas move from early-stage science int
A Father's Mission: How Danyelza Became a Life-Saving Therapy for Pediatric Neuroblastoma with Dr. Nai-Kong Cheung, Dr. Yashodhara Dash & Dr. Imke Ehlers-Surur Mar 25, 2026 2264 Sometimes the most powerful innovations come from the most personal places. This episode tells the extraordinary story of Danyelza (naxitamab), a life-saving immunotherapy for children with neuroblastoma, and how it earned a finalist spot in the AUTM Better World Project.What makes this story truly remarkable isn't just the science, although that's impressive enough. It's the unlikely

Recommended

Playing